Early down-regulation of Bcl-xL expression during megakaryocytic differentiation of thrombopoietin-induced CD34+ bone marrow cells in essential thrombocythemia - Zhang, L; Zhao, H; Sun, A; Lu, S; Liu, B; Tang, F; Feng, Y; Zhao, L; Yang, R; Han, ZC (Haematologica (Roma), 2004)
Keywords: Adult; Apoptosis - drug effects; bcl-X Protein - biosynthesis; bcl-X Protein - genetics; bcl-X Protein - physiology; Bone Marrow Cells - drug effects; Cell Differentiation - drug effects; Cell Line, Tumor - drug effects; Cell Line, Tumor - pathology; Cells, Cultured - drug effects; Cells, Cultured - pathology; Culture Media, Serum-Free - pharmacology; Down-Regulation - drug effects; Female; Gene Targeting; Humans; K562 Cells - drug effects; K562 Cells - pathology; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology; Male; Megakaryocytes - pathology; Middle Aged; Polycythemia Vera - pathology; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering - pharmacology; Thrombocythemia, Essential - pathology; Thrombopoietin - pharmacology; Transfection